As the experts in digestive and metabolic medicine and as afamily-owned business with a global presence, we focus ondeveloping and marketing innovative medicines to treat a wide rangeof gastrointestinal disorders like inflammatory bowel disease oreosinophilic esophagitis as well as hepatobiliary disorders such asprimary biliary cholangitis. Our aim: to meaningfully improvetherapeutic practice as well as patient health and well-being. Wefirmly believe that medical progress can only be achieved byworking together. That is why we are looking for:
APCT1_DE